Legal & General Group PLC Alvotech Transaction History
Legal & General Group PLC
- $357 Billion
- Q1 2025
A detailed history of Legal & General Group PLC transactions in Alvotech stock. As of the latest transaction made, Legal & General Group PLC holds 562,411 shares of ALVO stock, worth $5.5 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
562,411
Previous 576,189
2.39%
Holding current value
$5.5 Million
Previous $7.61 Million
28.49%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ALVO
# of Institutions
50Shares Held
15.8MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA4.19MShares$41 Million0.0% of portfolio
-
Bracebridge Capital, LLC2.71MShares$26.5 Million20.4% of portfolio
-
Howard Marks Oaktree Capital Management LP | Los Angeles, Ca1.87MShares$18.3 Million0.54% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.4MShares$13.7 Million0.0% of portfolio
-
Littlejohn & CO LLC1.32MShares$12.9 Million6.46% of portfolio
About Alvotech
- Ticker ALVO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 248,650,000
- Market Cap $2.43B
- Description
- Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders, as well as cancer. The company's lead program is AVT02, a high concentration formulation biosimilar to Humira to treat various inflammatory condi...